Remove Healthcare Remove Networking Remove Pharmaceutical manufacturing
article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.

article thumbnail

Tackling fake pharmaceuticals: an industry united against counterfeit products

European Pharmaceutical Review

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Essentially, both counterfeit and falsified medicines pose risks to public health and threaten to undermine the healthcare system and pharmaceutical industry. About the author.

article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Many companies use artificial intelligence (AI) to enable pharmaceutical manufacturers to overcome barriers to medication adherence.

Leads 52
article thumbnail

Bob Harrell

Pharma Marketing Network

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). The post Bob Harrell appeared first on Pharma Marketing Network.

article thumbnail

Top-10 ways for Pharma to leverage AI according to…AI

Impetus Digital

Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology.

Pharma 92
article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. NovaXS is on a mission to simplify the medication self-administration process and improve remote healthcare adherence. billion in 2030 at a CAGR of 9.2%.

article thumbnail

The cluster effect: Connectivity and collaboration in life sciences hubs

Pharmaceutical Technology

Take Charleston, South Carolina, for example, where a growing number of medical device and pharmaceutical manufacturers, research laboratories and service companies have sprung up or settled in recent years. dollar grant towards the Foundation’s Lowcountry Healthcare Careers Collaborative.

Medical 52